IVA – inventiva s.a. - american depository shares (US:NASDAQ)
Stock Stats
News
Non-Alcoholic Steatohepatitis (NASH) Pipeline Insight, 2024 Featuring 100+ Companies and 110+ Pipeline Drugs Including Lanifibranor (Inventiva Pharma), MSDC-0602K (Cirius Therapeutics), TERN-501 (Terns Pharma) [Yahoo! Finance]
Inventiva S.A. (NASDAQ: IVA) had its price target raised by analysts at Canaccord Genuity Group Inc. from $12.00 to $20.00. They now have a "buy" rating on the stock.
Inventiva announces filing of its 2023 Universal Registration Document and 2023 Annual Report on Form 20-F [Yahoo! Finance]
Inventiva announces filing of its 2023 Universal Registration Document and 2023 Annual Report on Form 20-F
Inventiva S.A. (NASDAQ:IVA) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Form SC 13D/A Inventiva S.A. Filed by: New Enterprise Associates 17, L.P.
Form 20-F Inventiva S.A. For: Dec 31
Form 6-K Inventiva S.A. For: Mar 27
Form 6-K Inventiva S.A. For: Mar 18
Form 6-K Inventiva S.A. For: Mar 07
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.